[Melioidosis].
Miyagi
Kei
K
First Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus.
Saito
Atsushi
A
D042462:4-Quinolones; D000890:Anti-Infective Agents / Q000494:pharmacology / Q000627:therapeutic use; D016957:Burkholderia pseudomallei / Q000187:drug effects; D015780:Carbapenems / Q000494:pharmacology / Q000627:therapeutic use; D002511:Cephalosporins / Q000494:pharmacology / Q000627:therapeutic use; D003937:Diagnosis, Differential; D024881:Drug Resistance, Bacterial; D006801:Humans; D008554:Melioidosis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology / Q000503:physiopathology
D042462:4-Quinolones; D000890:Anti-Infective Agents; D015780:Carbapenems; D002511:Cephalosporins